Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Actelion, adapt, Adherium, advocacy, aes, alanine, aminotransferase, antispasticity, Argentina, array, ASCO, Austin, Australasia, Autumn, bachelor, batch, Bebin, biosimilar, Bishopsgate, BLA, blockade, bottling, breakthrough, cap, cast, catalyst, cation, caution, Chase, Chicago, CID, closer, CODM, Cologne, Commissioner, compendia, competitior, contrary, convene, correlated, crystallize, CV, Dame, dantrolene, Decker, dental, Denver, depolarization, Detroit, distributor, doctorate, dossier, Doug, eIND, Eisai, ELT, Ernst, ester, exceedingly, FADAMA, favourable, fellowship, fold, Forest, gastric, GesmbH, Giacobello, Haven, headache, Henderson, highlighted, immigration, incentivize, influx, intensifying, intracellular, inVentiv, Joseph, Kent, Knappertz, KPMG, lab, Laurence, Laux, levetiracetam, Liaison, longest, lung, MAA, machinery, Malaysia, Master, Mater, MCID, melanoma, Memo, mg, Misericordiae, mono, move, moving, NAFTA, Natex, NC, neurologist, NIDA, NIH, Notre, ONDCP, organizational, outplacement, outreach, overactive, oversaw, packing, partly, PDUFA, pharmacovigilance, phenotype, PK, plausible, Prepayment, prerequisite, problem, Prozesstechnologie, Pty, purse, QOL, QOLCE, Rannazzisi, Rannazzissi, rapporteur, readjusting, refocusing, regenerative, reminding, renal, reorganisation, reorganised, repolarization, reprice, Rosenberg, salt, SAVANT, scientist, Scott, sixteen, SNO, Snyder, spontaneously, subset, SUPED, symposium, synaptic, tangible, testimony, Teva, topiramate, touch, unvested, upcoming, vacated, visibility, Volker, voucher, Wacker, Wake, workforce, Yale
Removed:
Abbott, acetylcholine, advantaged, aetiology, amalgamation, antagonism, antagonistic, antipsychotic, approached, attaining, attenuate, Aug, augmentation, bear, begun, blunted, cancellation, capitalized, carbon, Carlo, chance, climate, concept, conductin, Dec, desensitizer, dioxide, dried, educational, EMI, enterprise, euphoric, feet, force, forde, harvest, harvested, indoor, ineligible, inInternal, Jun, microglial, milled, Monte, mood, motivation, multifactorial, myoclonic, nerve, Neuroscience, neurotransmission, nitric, Nov, Ohtahara, orally, oversee, oxide, PCAOB, perturbation, pleasure, poorly, predominately, programmed, progressive, proof, putative, rarer, realizable, reassessed, relevance, remained, remission, repressed, reproducible, restructuring, retire, sanctioned, sentence, Sep, significance, square, stimulated, structural, surgery, Sweden, theInternal, TNF, Tom, toxic, triple, vitroandin
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.63 Exhibit 4.63
- 4.64 Exhibit 4.64
- 4.65 Exhibit 4.65
- 4.66 Exhibit 4.66
- 4.67 Exhibit 4.67
- 4.68 Exhibit 4.68
- 4.69 Exhibit 4.69
- 4.70 Exhibit 4.70
- 4.71 Exhibit 4.71
- 4.72 Exhibit 4.72
- 4.73 Exhibit 4.73
- 4.74 Exhibit 4.74
- 4.75 Exhibit 4.75
- 4.76 Exhibit 4.76
- 4.77 Exhibit 4.77
- 4.78 Exhibit 4.78
- 4.79 Exhibit 4.79
- 4.80 Exhibit 4.80
- 4.81 Exhibit 4.81
- 4.82 Exhibit 4.82
- 4.83 Exhibit 4.83
- 8.1 Exhibit 8.1
- 12.1 Exhibit 12.1
- 12.2 Exhibit 12.2
- 13.1 Exhibit 13.1
- 13.2 Exhibit 13.2
- 15.1 Exhibit 15.1
Associated GWPRF transcripts
GWPRF similar filings
Filing view
External links
Exhibit 13.1
Section 906 Certificate
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Justin Gover, Chief Executive Officer of GW Pharmaceuticals plc, a public limited company incorporated under English law (the “company”), hereby certify, to my knowledge, that:
1. | The Annual Report on Form 20-F for the year ended September 30, 2017 (the “Form 20-F”) of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the company. |
Date: December 4, 2017
/s/ Justin Gover | |
Justin Gover | |
Chief Executive Officer |